Figure 4.
Duration of the vaccine’s effectiveness conferred by the primary series. (a) People ≥16 years of age; (b) people ≥16 and <60 years of age. The dots in the bar chart show the effectiveness of the vaccine against death and severe infection/hospitalization in the studies in the real word we collected at different periods after completion of the primary series.